Advent International

Advent International's $1 Billion Bet on NZCR: Why Private Equity Is Targeting Clinical Research Organizations

TL;DR: On August 20, 2026, Advent International announced a majority-stake acquisition of New Zealand Clinical Research Group (NZCR) in a deal valued at approximately NZD $1 billion. Existing sharehol